drugset / Trial / NCT02665234
A Safety and Efficacy Study of Tavilermide (MIM-D3) Ophthalmic Solution for the Treatment of Dry Eye Disease
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to assess the safety and efficacy of Tavilermide Ophthalmic Solution compared with Placebo Ophthalmic Solution in treating the signs and symptoms of dry eye disease.
Timeline
- Start
- 2016-01
- Primary completion
- 2017-02
- Completion
- 2017-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Tavilermide | Protein / enzyme biologic | 1 % | Other |